Skip to contentA
Astrana Health, Inc.
A
ASTHAstrana Health, Inc. Q2 2013 · 10-Q
Revenue$2.59M$2.59M+57.2% vs Q2 2012 Net Income-$1.53M-$1.53MN/M vs Q2 2012 EPS Diluted-$0.04-$0.04N/M vs Q2 2012 Gross Profit$226,653−48.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Astrana Health, Inc. · CIK 1083446 · Engraved from SEC EDGAR
Operating Cash Flowderived-$311,316N/M Free Cash Flowderived-$319,890N/M Margins · derivedGross margin8.7%−18.2 pt vs Q2 2012
Operating margin-52.5%−48.6 pt vs Q2 2012
Net margin-59.1%+135.1 pt vs Q2 2012
ended Jul 31, 2013 · filed Sep 16, 2013 · 47 d after period end